Zealand Pharma

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

AdipoPharma

This clinical-stage biotechnology company develops therapeutic peptides to treat insulin resistance and type 2 diabetes for patients with metabolic disorders.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

AdipoPharma SAS

This biotech company develops a therapeutic peptide to treat insulin resistance and type 2 diabetes for patients with metabolic diseases.

Hawkhill Therapeutics

This company develops oral small molecule therapies for obesity and metabolic health to preserve muscle mass for the biotechnology and pharmaceutical sectors.

Novo Nordisk

This pharmaceutical company manufactures medicines for patients living with diabetes, obesity and other serious chronic diseases.

Metsera

The company develops injectable and oral medicines for patients with obesity and metabolic diseases.

Altimmune

This biopharmaceutical company develops peptide-based therapeutics for patients with obesity and liver diseases, including metabolic dysfunction-associated steatohepatitis and alcohol-associated liver disease.